000 | 01017 a2200325 4500 | ||
---|---|---|---|
005 | 20250518090314.0 | ||
264 | 0 | _c20200707 | |
008 | 202007s 0 0 eng d | ||
022 | _a1499-2752 | ||
024 | 7 |
_a10.3899/jrheum.191150 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDay, Richard Osborne | |
245 | 0 | 0 |
_aPredictors of Success in Gout Treatment. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _c03 2020 |
||
300 |
_a313-315 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAllopurinol |
650 | 0 | 4 | _aGout |
650 | 0 | 4 | _aGout Suppressants |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aUric Acid |
650 | 0 | 4 | _aVeterans |
700 | 1 | _aColeshill, Mathew James | |
700 | 1 | _aStocker, Sophie Lena | |
700 | 1 | _aNguyen, Amy Danh | |
700 | 1 | _aRobinson, Philip | |
700 | 1 | _aAung, Eindra | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 47 _gno. 3 _gp. 313-315 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.191150 _zAvailable from publisher's website |
999 |
_c30689790 _d30689790 |